Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
RELATED PRODUCTS
-
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
STANNOUS CHLORIDE
STANNOUS CHLORIDEIt is indicated for: - Performing scintigraphic studies of the blood pool of the heart and great vessels. - Circulatory and placental studies. - Evaluation of gastrointestinal bleeding (especially to locate... -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.

